During the past decade, Marienhospital Bottrop gGmbH conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 1 clinical trials were completed, i.e. on average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marienhospital Bottrop gGmbH" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Daiichi Sankyo, Inc." with 2 trials sponsored, "University Hospital Tuebingen" with 2 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "European Breast Cancer Reseach Association of Surgical Trialists" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marienhospital Bottrop gGmbH" #1 collaborator was "UNICANCER" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "German Breast Group" with 2 trials as a collaborator and "AGO-B" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Marienhospital Bottrop gGmbH" are "Breast Cancer" (5 trials), "Metastatic Breast Cancer" (3 trials), "Leukemia" (2 trials), "Breast Neoplasms" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Marienhospital Bottrop gGmbH" in a lesser frequency.

Most popular intervention types in "Marienhospital Bottrop gGmbH" are "Drug" (12 trials), "Biological" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (3 trials), "Rituximab" (2 trials), "Trastuzumab" (2 trials), "trastuzumab" (2 trials) and "Ado-trastuzumab emtansine (T-DM1)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marienhospital Bottrop gGmbH" are 13 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Marienhospital Bottrop gGmbH". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Marienhospital Bottrop gGmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marienhospital Bottrop gGmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Marienhospital Bottrop gGmbH has several departments that took part in Clinical trials: "Department for Gynecology and Obstetrics, Marienhospital Bottrop gGmbH" - 3 trials